OptimizeRx Corp (OPRX) › Shareholders' EquityOptimizeRx Corp (OPRX) — Shareholders' EquityAnnual figures by period end, from SEC filings.2010-12-31: $1.89M2011-12-31: $1.59M2012-12-31: $1.40M2013-12-31: $1.67M2014-12-31: $4.61M2015-12-31: $8.94M2016-12-31: $7.81M2017-12-31: $6.22M2018-12-31: $18.46M2019-12-31: $44.86M2020-12-31: $49.97M2021-12-31: $131.38M2022-12-31: $126.11M2023-12-31: $126.55M2024-12-31: $117.00M2025-12-31: $128.29M$128.29M2010-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$128.29M+9.7%2026-03-12Balance as of period end2024-12-31$117.00M-7.6%2026-03-12Balance as of period end2023-12-31$126.55M+0.4%2026-03-12Balance as of period end2022-12-31$126.11M-4.0%2025-03-20Balance as of period end2021-12-31$131.38M+162.9%2024-04-15Balance as of period end2020-12-31$49.97M+11.4%2023-03-10Balance as of period end2019-12-31$44.86M+143.0%2023-03-10Balance as of period end2018-12-31$18.46M+196.7%2021-03-08Balance as of period end2017-12-31$6.22M-20.4%2020-03-26Balance as of period end2016-12-31$7.81M-12.6%2019-03-12Balance as of period end2015-12-31$8.94M+94.0%2018-03-08Balance as of period end2014-12-31$4.61M+176.4%2017-03-08Balance as of period end2013-12-31$1.67M+18.7%2016-03-15Balance as of period end2012-12-31$1.40M-11.6%2015-09-16Balance as of period end2011-12-31$1.59M-16.1%2014-03-31Balance as of period end2010-12-31$1.89M—2013-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)